Show simple item record

dc.contributor.authorSong, Yee Pei
dc.contributor.authorMorrison, S
dc.contributor.authorLyons, Jeanette
dc.contributor.authorPatel, Kamlesh
dc.contributor.authorCoyle, Catherine
dc.contributor.authorElliot, P
dc.contributor.authorLogue, John P
dc.contributor.authorTran, Anna T
dc.contributor.authorWylie, James P
dc.contributor.authorConroy, Ruth
dc.contributor.authorChoudhury, Ananya
dc.date.accessioned2018-11-12T14:50:36Z
dc.date.available2018-11-12T14:50:36Z
dc.date.issued2018
dc.identifier.citationDocetaxel - Mitigating the high price of success. 2018, 127:S854 Radiother Oncolen
dc.identifier.urihttp://hdl.handle.net/10541/621321
dc.language.isoenen
dc.relation.urlhttps://www.thegreenjournal.com/article/S0167-8140(18)31895-4/pdfen
dc.titleDocetaxel - Mitigating the high price of success.en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Clinical Oncology, Manchester,en
dc.identifier.journalRadiotherapy and Oncologyen


This item appears in the following Collection(s)

Show simple item record